Articles in section Features

<< Editorial

167 articles

General >>

<< Previous

Pages 1 ..11 12 13 14 15 16 .. 17

Next >>

Therapy Focus: Schizophrenia Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 64
AstraZeneca and Early-Stage Deal Making Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 63
Biogen Idec and PDL: Licensing Triumphs over Acquisition Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 63
Baltic States Bring Biotech Expertise to Enlarged Europe Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 63
Therapy Focus: Rheumatoid Arthritis Published: 1 Sep-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 63
Alkermes, Cephalon and Vivitrex#174;: Pioneering the Alcohol Dependence Market Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 62
Pfizer and Vicuron: A Taste of Things to Come? Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 62
The Supreme Court Changes Biotech Deal Flow Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 62
Therapy Focus: Acute Myeloid Leukaemia Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 62
Serono Continues its Deal Making Spree through Collaborations with BioMarin and NovImmune Published: 1 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 61

Login

Username:

Password:

Keep me logged in